A systematic review and meta-analysis on SARS-COVID-2, its molecular virology, transmission & seroprevalence worldwide

In Wuhan, China (2019), an immediate flare-up of corona virus occurred in the human body to introduce a mortal corona virus which not only affects the human health system, but also affect the global economic approach of the world. The virus is the single-chain of positive sensation of RNA that has structural and non-structural proteins. The ACE2 receptor is bound by SARS-CoV-2 in human cells and has its polymerase RNA. While we have seen a big leap in our understanding of corona viruses after two precedents, there are still a few successful methods of treatment and epidemiological surveillance are both important. The corona virus is spreading on a fearful revealing the world that covered the 200 countries in the universe. Current epidemiological and clinical evidences from early Wuhan studies was updated to highlight a range of SARS-CoV-2 features, which differentiate greater fluctuation between the SARS-CoV and the MERS virus of the Middle East (MERS) have been named by the World Health Organization (WHO). The latest clinical trial of the Covid-19 pandemic is systematized. Although studies are currently being performed on different vaccines for the genome of SARS-CoV-2 and therapeutic antibodies, this is a more long-term approach, because it requires a comprehensive safety check.